A Double-Blind, Placebo-Controlled Study of Intravenous Peramivir in Acute Influenza Patients

Trial Profile

A Double-Blind, Placebo-Controlled Study of Intravenous Peramivir in Acute Influenza Patients

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Oct 2014

At a glance

  • Drugs Peramivir (Primary)
  • Indications Influenza virus infections
  • Focus Registrational; Therapeutic Use
  • Sponsors Shionogi
  • Most Recent Events

    • 16 Aug 2010 Results were published in Antimicrobial Agents and Chemotherapy.
    • 04 Nov 2009 According to a Shionogi media release, a New Drug Application has been filed based on the results of this and another trial (see profile 700047064).
    • 31 Oct 2008 Secondary endpoints met according to BioCryst media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top